By stratifying PDA patients on the basis of gene expression, we found that the highest quartile of patients expressing each of the “Tr1-related genes”—CD49b, CD73, and AHR—exhibited decreased overall survival (OS) (Fig. 6a). This evidence concerns the gene NT5E and Patent ductus arteriosus.